Incidence and characteristics of perioperative pulmonary thromboembolism in Japan in 2003

Japanese Journal of Anesthesiology

Volumn 54, Issue 7, 2005, Pages 822-828

  Kuroiwa, Masayuki ^a   Furuya, Hitoshi ^b   Seo, Norimasa ^c   Irita, Kazuo ^d   Sawa, Tomohiro ^e   Sasaki, Junji ^f   Ito, Makoto ^g  

^a SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e TEIKYO UNIVERSITY   (Japan)

^f TOKYO RINKAI HOSPITAL   (Japan)

^g Iwakuni Medical Center   (Japan)

Author keywords

Morbidity; Mortality; Perioperative pulmonary thromboembolism; Risk factor

Indexed keywords

ABDOMINAL SURGERY; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HEART ARREST; HIP SURGERY; HUMAN; INCIDENCE; JAPAN; LAPAROTOMY; LIMB; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; OBESITY; PERIOPERATIVE PERIOD; QUESTIONNAIRE; RISK FACTOR; SHOCK; THORAX SURGERY; THROMBOSIS PREVENTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTRAOPERATIVE COMPLICATIONS; JAPAN; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; QUESTIONNAIRES; RISK FACTORS;

EID: 22444440994     PISSN: 00214892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Kitamukai O, Sakuma M, Takahashi T, Kagaya Y, Watanabe J, Shirato K. Incidence and characteristics of pulmonary thromboembolism in Japan 2000. Intern Med 2003; 42: 1090-4.
2. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 suppl): 338 S-400 S.
3. Agnelli G. Prevention of venous thromboembolism in surgical patients. Circulation 2004; 110 (24 suppl 1): IV 4-12.
4. Kwong. Hip fracture and venous thromboembolism in the elderly. J Surg Orthop Adv 2004; 13 (3): 139-48.
5. Bjorvatn A, Kristiansen F. Fondaparinux sodium compared with enoxaparin sodium: a cost-effectiveness analysis. Am J Cardiovasc Drugs 2005; 5: 121-30.
6. Bauersachs RM. Fondaparinux: an update on new study results. Eur J Clin Invest 2005; 35 suppl 1: 27-32.
7. Bramlage P, Pittrow D, Kirch W. Current concepts for the prevention of venous thromboembolism. Eur J Clin Invest 2005; 35 suppl 1: 4-11.
8. Futterman LG, Lemberg L. A silent killer-often preventable. Am J Crit Care 2004; 13: 431-6.
9. http:// www.jsth.org/12 indices/gaido.php
10. Ota M, Nakamura M, Yamada N, Yazu T, Ishihara K, Hiraoka N, et al. Prognostic significance of early diagnosis in acute pulmonary thromboembolism with circulatory failure. Heart Vessels 17; 2002: 7-11.